Cue Effects in Human Addiction: Pavlovian to Instrumental Transfer
Charite University, Berlin, Germany
300 participants
Nov 24, 2020
OBSERVATIONAL
Conditions
Summary
Individuals with substance use disorders (SUD) have to cope with drug-related cues and contexts, which can affect instrumental drug seeking as shown with Pavlovian to instrumental transfer (PIT) paradigms in animals and humans. The investigators aimed to investigate the impact of acute and chronic stress on Pavlovian-to-instrumental transfer (PIT), how PIT it is associated with cognitive control abilities and whether such effects predict losing vs. regaining control in subjects with AUD. Moreover, the investigators aimed to develop a novel full transfer task that assesses both, general and specific PIT to investigate whether specific PIT differs between alcohol use disorder (AUD) and control subjects.
Eligibility
Inclusion Criteria8
- males and females between 16-65 years of age
- AUD subjects only: meet a minimum of 2 criteria for DSM-5 alcohol-related disorder (AUD) (not requiring withdrawal as assessed by an independent psychiatrist) and AUDIT \> 4
- Smokers: Daily smokers only: smoke 7 days/week during the last three months
- Non-daily smokers only: smoke at least once but less than 7 days/week during the last three months
- Ability to consent to the study and complete the questionnaires
- Sufficient language skills: German
- Availability between 3pm-6pm on 2 consecutive days (Experiment 1, acute stress question)
- Females only: luteal phase (Experiment 1, acute stress question)
Exclusion Criteria12
- Lifetime diagnosis according to DMS-5 for: Bipolar disorder, schizophrenia, schizophrenia spectrum disorder, substance dependence except for alcohol, nicotine, or cannabis
- Currently meeting DSM-5 diagnostic criteria for a depressive episode, suicidal ideation
- Past traumatic brain injury or severe neurological disease (such as dementia, Parkinson's disease, multiple sclerosis)
- Pregnancy or breastfeeding
- Ingestion of medications known to interact with the CNS in the 10-day period prior to study participation or less than 4 half-lives after last ingestion (rapid urine test)
- MR contraindications (e.g., pacemakers, metallic or electronic implants, metallic splinters, surgical staples)
- Color vision deficiency
- Sensorineural hearing loss of 30 dB or greater,
- Tinnitus
- Presence of claustrophobia
- Acute alcohol intoxication at MRI appointments verified by breath alcohol testing or drug intoxication verified by rapid urine testing
- For women only: not peri- or postmenopausal, not taking contraceptives (Experiment 1, acute stress question)
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Will be used to investigate neural correlates of PIT effects by measuring the blood oxygenation level dependent (BOLD) response of neural activation in the mesolimbic system.
Will be used to investigate neural correlates of PIT effects by identifying abnormalities in cortical gray and white matter volume.
Will be used to assess the effect of acute stress induction on behavioral and neural PIT effects. The induced stress is generated in a social context, where the participants are asked to prepare a job interview for their dream job and to present it in front of a three-member jury.
The paradigm consists of four parts: In the first part, an instrumental learning task is completed in which subjects must learn which stimuli require a response and which do not. In the second part, a classical (Pavlovian) conditioning task is then completed in which subjects learn by passive viewing which stimuli are associated with certain amounts of money. The third part measures to which instrumental responses (learned in Part 1) are modulated by the presentation of the classically conditioned stimuli (learned in Part 2). At the same time drug-associated stimuli are presented in the background measuring to which extent they conflict with the learned instrumental behavior. In the last part, query trials are implemented in which the participants have to choose between two pictures to assess the relative cue value.
Will be used to assess interference at stimulus level. Here either one, two, three or four identical digits from 1 to 4 are shown. Number and denotation of digits are either congruent (1, 22, 333, 4444; 88 trials) or incongruent (111, 2222, 3, 4444; 88 trials). Subjects have to indicate how many digits were shown
Will be used to measure interference at the response level and response inhibition. We will show arrows either pointing to the left or right. The arrow can either be shown on the left or the right side of the display. In congruent trials, direction and position are the same, whereas they differ in incongruent trials. Participants have to indicate the direction of the arrow and ignore the position.
Will be used to examine inhibitory control. The participants tap the left and right side of the screen to smash two falling fruits. When the fruits pass two circles, subjects are required to tap both sides of the screen. In "stop trials" one of the fruits turns brown (rotten), indicating the corresponding side of the screen should not be tapped.
for genetic and epigenetic testing, especially for exploratory outcome prediction using polygenic risk scores.
* Perceived Stress Scale * Social Readjustment Rating Scale * Trier Inventory for the Assessment of Chronic
Hair cortisol measurement (3 cm hair segments) will be used to assess chronic stress.
Assessing acute stress effects in AUD.
We will use smartphones with additional mobile sensors (wearables), which will be used to measure physical activity, data on location (GPS), geolocation-based triggering of e-Diaries, self-reported stress reactivity, cue exposure (encounters with drug-related stimuli in real life), drug craving, impulsivity and drug consumption (priming doses, binges and continuous use of all drugs of abuse).
SKID-I Interview neurocognitive and psychopathological testing
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05992272